ABL1 Kinase as a Tumor Suppressor in AML1-ETO and NUP98-PMX1 Leukemias

To pinpoint mechanisms facilitating the transformation of ABL1-deficient cells, Abl1 was knocked down in 32Dcl3-Abl1ko cells by CRISPR/Cas9 followed by the challenge of growth factor withdrawal.